coagulation factor VIII


Also found in: Acronyms.

coagulation factor VIII

Factor VIII, see there.
References in periodicals archive ?
The Global Human Coagulation Factor VIII Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Human Coagulation Factor VIII industry.
This competition aims at the selection of cocontratantes for the framework agreement that will allow the acquisition of factors VIII and IX of human coagulation factor VIII human coagulation + human von Willebrand factor and von Willebrand human factor listed in Annex I to notebook charges.
The majority of the drugs available in the market belong to the substitution of coagulation factor VIII drug class.
This 2013 Deep Research Report is a professional and in-depth research report on the Global and Chinese Human Coagulation Factor VIII industry.
Total quantity or scope: Coagulation Factor VIII and von Willebrand factor: Cant.
Lot 7 - human coagulation Factor VIII and von Willebrand factor;
Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the production or function of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B).
Contract notice: Coagulation factor viii concentrate at least second-generation recombinant home delivery patient / hemophilia treatment center; sign of things: zzp-69/15.
The coagulation factor VIII used for Hemophilia therapy will be altered in such a way that the immune system of the patients may not respond by developing inhibitory antibodies.
8 sgb v be delivered directly to hospitals and doctors to recombinant coagulation factor viii concentrates, which according to A* 47 para.
In addition, except human coagulation factor VIII with a decreased lot release volume, other products saw growing release volume.

Full browser ?